Carson Wealth (CWM LLC)
NKTR icon

Carson Wealth (CWM LLC)’s Nektar Therapeutics NKTR Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7K Sell
176
-29
-14% -$1.65K ﹤0.01% 4684
2025
Q4 		$9K Sell
205
-38
-16% -$2.13K ﹤0.01% 4603
2025
Q3 		$14K Sell
243
-11,710
-98% -$388K ﹤0.01% 4317
2025
Q2 		$309K Buy
11,953
+4,918
+70% +$55.2K ﹤0.01% 1846
2025
Q1 		$72K Buy
7,035
+6,884
+4,559% +$89.9K ﹤0.01% 2688
2024
Q4 		$2K Sell
151
-73
-33% -$1.29K ﹤0.01% 4572
2024
Q3 		$4K Buy
+224
New +$4.27K ﹤0.01% 4197
2024
Q2 		– Sell
-17
Closed – – 4813
2024
Q1 		$0 Hold
17
– – ﹤0.01% 4594
2023
Q4 		$0 Hold
17
– – ﹤0.01% 4395
2023
Q3 		$0 Hold
17
– – ﹤0.01% 4419
2023
Q2 		$0 Hold
17
– – ﹤0.01% 4371
2023
Q1 		$0 Sell
17
-39
-70% -$1.18K ﹤0.01% 4250
2022
Q4 		$2K Sell
56
-289
-84% -$14K ﹤0.01% 3599
2022
Q3 		$17K Buy
345
+335
+3,350% +$19.9K ﹤0.01% 2336
2022
Q2 		$1K Sell
10
-165
-94% -$10.4K ﹤0.01% 3583
2022
Q1 		$14K Buy
175
+158
+929% +$23.4K ﹤0.01% 2302
2021
Q4 		$3K Buy
+17
New +$3.69K ﹤0.01% 3003
2021
Q2 		$2K Hold
7
– – ﹤0.01% 2680
2021
Q1 		$2K Hold
7
– – ﹤0.01% 2680
2020
Q4 		$2K Hold
7
– – ﹤0.01% 2679
2020
Q3 		$2K Hold
7
– – ﹤0.01% 2678
2020
Q2 		$2K Hold
7
– – ﹤0.01% 2677
2020
Q1 		$2K Hold
7
– – ﹤0.01% 2677
2019
Q4 		$2K Hold
7
– – ﹤0.01% 2676
2019
Q3 		$2K Hold
7
– – ﹤0.01% 2676
2019
Q2 		$2K Hold
7
– – ﹤0.01% 2676
2019
Q1 		$2K Buy
7
+4
+133% +$2.37K ﹤0.01% 2674
2018
Q4 		$1K Buy
+3
New +$1.81K ﹤0.01% 1944

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Carson Wealth (CWM LLC)'s NKTR Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Nektar Therapeutics (NKTR) stake by 14% in Q1 2026, selling an estimated $1.65K and leaving 176 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4684.

Carson Wealth (CWM LLC) first reported a position in NKTR in Q4 2018 and has held it in 28 quarters since. The position peaked at $309K in Q2 2025. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Carson Wealth (CWM LLC) held 176 shares of Nektar Therapeutics worth $12.7K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 29 Nektar Therapeutics shares in Q1 2026, an estimated $1.65K.
  • Nektar Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4684 holding.
  • Carson Wealth (CWM LLC) first reported a position in Nektar Therapeutics in Q4 2018 and has held it in 28 quarters since.
  • Carson Wealth (CWM LLC)'s Nektar Therapeutics position peaked at $309K in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.